Date: May 17, 2022 to May 19, 2022
Where: Embassy Suites by Hilton Boston at Logan Airport, 207 Porter Street,, Suffolk County, Massachusetts, United States, 02128
Event Type: Other
Ticket Price: N/A
As Biopharma turn their focus to autoimmune drug development, there has been an explosion of interest and investment into Treg directed therapies. Promising proof-of-concept data and early clinical read outs have fueled further hype, and the industry now looks to demonstrate efficacy.\ \ The 4th Treg Directed Therapies Summit returns to Boston this May, bigger and better than ever before, boasting 2 tracks of unparalleled content to cater to cell-based, and non-cell-based experts alike. This is the only industry-focused meeting designed to bridge the gap between early discovery through clinical development of cell-based and non cell-based Treg directed therapies to provide efficacious treatments for patients globally.\ \ With 3 days of unrivalled content spanning the fundamental biology of Tregs, optimizing early drug development, and streamlining clinical development, join with your team to:\ \ Optimize stable expansion of Tregs to maintain function to elicit durable responses\ \ Decode Treg interactions to optimize the mechanism of actions and inform biomarker development\ \ Rationalize activation, formulation & delivery strategy to induce antigen specific tolerance \ \ Supercharge CMC strategy to drive the modulation of antigen-specific responses to yield maximum clinical efficacy\ \ 200+ senior level drug developers will be uniting in May to chase the holy grail of Treg-directed therapies. Don’t miss your chance to network with the avant-garde to inform your Treg pipeline and capitalize on the shared knowledge of this collaborative community.